Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators? - Institut Bergonié Accéder directement au contenu
Article Dans Une Revue JCO precision oncology Année : 2020

Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators?

Résumé

The amount of 'big' data generated in clinical oncology, whether from molecular, imaging, pharmacological or biological origin, brings novel challenges. To mine efficiently this source of information, mathematical models able to produce predictive algorithms and simulations are required, with applications for diagnosis, prognosis, drug development or prediction of the response to therapy. Such mathematical and computational constructs can be subdivided into two broad classes: biologically agnostic, statistical models using artificial intelligence techniques, and physiologically-based, mechanistic models. In this review, recent advances in the applications of such methods in clinical oncology are outlined. These include machine learning applied to big data (omics, imaging or electronic health records), pharmacometrics, quantitative systems pharmacology, tumor size kinetics, and metastasis modeling. Focus is set on studies with high potential of clinical translation, as well as applied to cancer immunotherapy. Perspectives are given in terms of combinations of the two approaches: 'mechanistic learning'.
Fichier principal
Vignette du fichier
final.pdf (592.64 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03147084 , version 1 (19-02-2021)

Identifiants

Citer

Joseph Ciccolini, Dominique Barbolosi, Nicolas André, Fabrice Barlesi, Sébastien Benzekry. Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators?. JCO precision oncology, 2020, 108 (4), pp.486-491. ⟨10.1200/PO.19.00381⟩. ⟨hal-03147084⟩
137 Consultations
243 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More